Biologics Done Right – AB SCIEX

As pharmaceutical organizations adapt to changing business models, and pressures from competitors and markets, they also need to develop biotherapeutics faster, with greater safety and improved efficacy profiles. As the global population ages, there is a growing pressure to keep the healthcare costs under control. The rise of biosimilars, harmonized global regulations for biologics, and greater use of single-use technology for bioproduction have increased pressure on efficient analysis. Whether it is characterization of a potential biotherapeutic, bioprocess optimization, formulation development, product monitoring via quality attributes, or comparability, SCIEX offers a wide variety of analytical techniques that satisfy biopharmaceutical discovery, development and production. With world-class offerings in separations, mass spectrometry, software and sample preparation, SCIEX helps its partners to enhance the productivity of their work. From finding contaminants such as Host Cell Proteins (HCPs), determining and monitoring Quality Attributes, profiling the released glycan profile of a glycosylated protein, to molecular weight determination, SCIEX has all the bases covered for a successful analytical strategy in determining all of the fine details of a protein therapeutic. www.absciex.com/applications/biologics

---

---